ZNF7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.871600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.854600E-01
Normal-vs-Stage2
6.876000E-01
Normal-vs-Stage3
1.906570E-01
Normal-vs-Stage4
9.451600E-01
Stage1-vs-Stage2
4.216400E-01
Stage1-vs-Stage3
2.516200E-02
Stage1-vs-Stage4
8.247400E-01
Stage2-vs-Stage3
1.525580E-01
Stage2-vs-Stage4
5.531600E-01
Stage3-vs-Stage4
2.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.282400E-01
Normal-vs-AfricanAmerican
2.369600E-01
Normal-vs-Asian
6.357200E-01
Caucasian-vs-AfricanAmerican
2.049200E-01
Caucasian-vs-Asian
6.907600E-01
AfricanAmerican-vs-Asian
4.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.015400E-01
Normal-vs-Female
6.834400E-01
Male-vs-Female
8.624000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.112600E-01
Normal-vs-Age(41-60Yrs)
9.693200E-01
Normal-vs-Age(61-80Yrs)
4.981800E-01
Normal-vs-Age(81-100Yrs)
8.374400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.236800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.841400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.828200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.613760E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.834000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.522400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.109600E-01
Normal-vs-Daily Drinker
7.804000E-01
Normal-vs-Weekly Drinker
6.478000E-01
Normal-vs-Occasional Drinker
6.272200E-01
Normal-vs-Social Drinker
6.179600E-01
Non Drinker-vs-Daily Drinker
5.072200E-01
Non Drinker-vs-Weekly Drinker
8.342200E-01
Non Drinker-vs-Occasional Drinker
5.028200E-02
Non Drinker-vs-Social Drinker
7.235000E-01
Daily Drinker-vs-Weekly Drinker
6.951400E-01
Daily Drinker-vs-Occasional Drinker
1.309560E-01
Daily Drinker-vs-Social Drinker
7.678800E-01
Weekly Drinker-vs-Occasional Drinker
1.009580E-01
Weekly Drinker-vs-Social Drinker
8.941000E-01
Occasional Drinker-vs-Social Drinker
8.485900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.509000E-01
Normal-vs-Grade 2
1.896220E-01
Normal-vs-Grade 3
1.749440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.502200E-01
Grade 1-vs-Grade 3
1.466980E-01
Grade 1-vs-Grade 4
3.509000E-01
Grade 2-vs-Grade 3
5.187800E-02
Grade 2-vs-Grade 4
1.896220E-01
Grade 3-vs-Grade 4
1.749440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.775000E-01
Normal-vs-NonDiabetic
7.957800E-01
Diabetic-vs-NonDiabetic
2.776600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.966000E-01
Normal-vs-NoPancreatitis
7.345000E-01
Pancreatitis-vs-NoPancreatitis
6.335000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.162600E-01
Normal-vs-N1
6.465400E-01
N0-vs-N1
4.102800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.404800E-01
Normal-vs-TP53-NonMutant
5.683000E-01
TP53-Mutant-vs-TP53-NonMutant
5.351900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
